Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Case Studies in Rare Disease Commercialization: Lessons Learned Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI
Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Case Studies in Rare Disease Commercialization: Lessons Learned Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI
